The inhibition of PTP1B activity has great promise for alleviating insulin and leptin resistance; hence, PTP-1BIs (PTP1B inhibitors) show potential for treating T2DM and other metabolic disorders [98]. Here, PTPN1 is linked to type 2 diabetes mellitus.